Clinical Trials Logo

Drug-Induced Nephropathy clinical trials

View clinical trials related to Drug-Induced Nephropathy.

Filter by:
  • Recruiting  
  • Page 1

NCT ID: NCT06122311 Recruiting - Clinical trials for Drug-Induced Nephropathy

Drug Nephrotoxicity Amelioration by N-acetylcysteine

Start date: July 16, 2023
Phase: N/A
Study type: Interventional

When treating individuals with febrile neutropenia, amphotericin B (AmB-d) is one of the most effective treatments against often fatal systemic fungal infections.Nephrotoxicity from amphotericin B can develop with an incidence of up to 80.This emphasizes the value of nephroprotectant agent use.Because of N-acetylcysteine's antioxidant, antiapoptotic, vasodilator properties and its therapeutic effects on contrast nephropathy. Acetylcysteine's impact on amphotericin B-induced nephrotoxicity in cancer patients is assessed.

NCT ID: NCT05613361 Recruiting - Acute Kidney Injury Clinical Trials

The Effect of Curcumin Against Colistin-induced Nephrotoxicity

Start date: January 1, 2023
Phase: Phase 3
Study type: Interventional

The goal of this study is to investigate the possible nephroprotective effect of curcumin in critically ill patients receiving colistin.